Hydrocodone products are now Schedule II Controlled Substances
Hydrocodone Combination Products (HCPs) have been moved from Schedule III to the more-restrictive Schedule II, effective Oct. 6, 2014. The U.S. Drug Enforcement Administration’s rescheduling of HCPs as a Schedule II Controlled Substance will increase restriction on prescribing and dispensing practices for HCPs. See Hydrocodone: Schedule II Controlled Substance for more information.
Effectively controlling the diversion
of controlled substances ...
The Texas Prescription Program was created to monitor Schedule II through Schedule V controlled substance prescriptions. Diversion of prescription drugs is a significant abuse problem and this program was created to be an efficient, cost-effective tool for investigating and preventing drug diversion.
Controlled Substances have valid medical uses. However, they also have potential for abuse and addiction. Federal controls monitor narcotics from manufacture through distribution to retail facilities. Most pharmaceutical drug diversion occurs at the retail/consumer level. The Texas Prescription Program can be used by practitioners and pharmacists to verify their own records and inquire about patients. In addition, the program can be used to generate and disseminate information regarding prescription trends.
Statutorily restricted access is available to practitioners and pharmacists to search the following: